Top Markets
#1 Official Trump Official Trump +34.04%
#2 Siacoin Siacoin +30.62%
#3 Melania Meme Melania Meme +20.35%
#4 EXOD EXOD +18.93%
#5 MowCat MowCat +18.67%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +18.42%
#7 Mubarak Mubarak +17.66%
#8 Unit Pump Unit Pump +17.61%
#9 Pump.fun Pump.fun +17.61%
#10 The Bitcoin Bull The Bitcoin Bull +14.61%
Coin of the day
Official Trump Official Trump
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Clasificación en acciones #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Precio por acción
$4.00
Última sincronización: 2026-08-20
Capitalización bursátil
$75.37M
Cambio (1 día)
0.00%
Cambio (1 año)
12.99%
País
US
Comercio RetinalGenix Technologies Inc. (RTGN)

Categoría

Healthcare
Ganancias de RetinalGenix Technologies Inc. (RTGN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di RetinalGenix Technologies Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de RetinalGenix Technologies Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
- -
DE